Clinical Trial

Compassionate Care and Organization of Healthcare Services for a Successful Transition in Rheumatology

Study acronym: BOOST-R
Recruiting
View on ClinicalTrials.gov →
Summary
The transition from pediatric to adult care is a critical period for young people with chronic inflammatory rheumatic diseases (CIRD) and is associated with risks of poor self-management, loss to follow-up, and disease worsening. Although structured transition programs have been recommended, real-world data on their effectiveness in rheumatology remain limited. Since 2018, a structured transition program has been implemented at Bicêtre University Hospital (AP-HP, France), combining early transition preparation, a therapeutic patient education (TPE) workshop, and a joint pediatric-adult transition consultation. Some patients benefit from both components, while others receive a transition consultation only. The BOOST-R study is a monocentric, non-interventional observational study designed to evaluate the impact of different transition modalities on self-management after transfer to adult care. The primary objective is to compare transition readiness, assessed using the validated French version of the Transition Readiness Assessment Questionnaire (TRAQ-FR), between patients who received a TPE workshop plus a transition consultation and those who received a transition consultation only. Secondary objectives include evaluating continuity of care after transition, identifying factors associated with successful transition, assessing the contribution of the RESRIP support network, and describing patients who did not benefit from structured transition support.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04-02 -> 2027-08-26 2026-04-22
minor Completion moved earlier: 2027-10-02 -> 2027-08-26 2026-04-22
Trial Details
NCT Number NCT07469787
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Chronic Inflammatory Rheumatic Diseases of Childhood, Juvenile-Onset Chronic Inflammatory Rheumatic Diseases, Transition of Care in Chronic Inflammatory Rheumatic Diseases
Enrollment 50 participants
Start Date 2026-02-26
Primary Completion 2027-08-26 (estimated)
Study Completion 2027-08-26 (estimated)
Updated on ClinicalTrials.gov 2026-04-21